These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

2014 related items for PubMed ID: 26898168

  • 1. The prognostic value of sentinel lymph node micrometastases in patients with invasive breast carcinoma.
    Cipolla C, Graceffa G, La Mendola R, Fricano S, Fricano M, Vieni S.
    Ann Ital Chir; 2015; 86():497-502. PubMed ID: 26898168
    [Abstract] [Full Text] [Related]

  • 2. [Incidence of axillary recurrence after a negative sentinel lymph node result in early stages of breast cancer: a 5-year follow-up].
    Ruano Pérez R, Ramos Boyero M, García-Talavera Fernández JR, Ramos Grande T, González-Orús JM, Gómez-Caminero López F, García Macias MC, Martín de Arriba A.
    Rev Esp Med Nucl Imagen Mol; 2012; 31(4):173-7. PubMed ID: 23067685
    [Abstract] [Full Text] [Related]

  • 3. Sentinel lymph node biopsy in patients with operable breast cancer treated with neoadjuvant chemotherapy.
    Rebollo-Aguirre AC, Gallego-Peinado M, Menjón-Beltrán S, García-García J, Pastor-Pons E, Chamorro-Santos CE, Ramos-Font C, Salamanca-Ballesteros A, Llamas-Elvira JM, Olea-Serrano N.
    Rev Esp Med Nucl Imagen Mol; 2012; 31(3):117-23. PubMed ID: 21676504
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Axillary recurrence rate in breast cancer patients with negative sentinel lymph node (SLN) or SLN micrometastases: prospective analysis of 150 patients after SLN biopsy.
    Langer I, Marti WR, Guller U, Moch H, Harder F, Oertli D, Zuber M.
    Ann Surg; 2005 Jan; 241(1):152-8. PubMed ID: 15622003
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Presence of intramammary lymph nodes in the preoperative lymphoscintigraphy to locate the sentinel lymph node. Clinical significance].
    Nogareda Z, Álvarez A, Perlaza P, Caparrós FX, Alonso I, Paredes P, Vidal-Sicart S.
    Rev Esp Med Nucl Imagen Mol; 2015 Jan; 34(2):83-8. PubMed ID: 25434980
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Factors affecting sentinel lymph node detection failure in breast cancer patients using intradermal injection of the tracer.
    Abdollahi A, Jangjoo A, Dabbagh Kakhki VR, Rasoul Zakavi S, Memar B, Naser Forghani M, Mehrabibahar M, Sadeghi R.
    Rev Esp Med Nucl; 2010 Jan; 29(2):73-7. PubMed ID: 19931946
    [Abstract] [Full Text] [Related]

  • 18. The Sentinel Node with Isolated Breast Tumor Cells or Micrometastases. Benefits and Risks of Axillary Dissection.
    Madekivi V, Boström P, Aaltonen R, Vahlberg T, Salminen E.
    Anticancer Res; 2017 Jul; 37(7):3757-3762. PubMed ID: 28668871
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Impact of completion axillary lymph node dissection in patients with breast cancer and isolated tumour cells or micrometastases in sentinel nodes.
    Houvenaeghel G, Boher JM, Reyal F, Cohen M, Garbay JR, Classe JM, Rouzier R, Giard S, Faure C, Charitansky H, Tunon de Lara C, Daraï E, Hudry D, Azuar P, Gimbergues P, Villet R, Sfumato P, Lambaudie E.
    Eur J Cancer; 2016 Nov; 67():106-118. PubMed ID: 27640137
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 101.